Wyatt's Practical Psychiatric Practice : Forms and Protocols for Clinical Use [With CDROM]

Foreword ix Preface to the Third Edition xi About the CD-ROM xiii Part 1: Physician Forms Initial Letter to Patients, Self-Assessment, and Release Forms Instructions for Using the Initial Letter to Patients and Self-Assessment Form 5(1) Initial Letter to Patients (Form 1--1) 6(1) Self-Assessment Form (Form 1--2) 7(9) Authorization for Release of Medical Records (Form 1--3) 16(1) Authorization for Release of Information (Form 1--4) 17(1) Patient-Physician Authorizations and Agreements (Form 1--5) 18(1) Invoice for Services Rendered (Form 1--6) 19(1) Final Collection Notice (Form 1--7) 20(3) History and Documentation Forms Initial Psychiatric History and Assessment (Form 1--8) 23(6) Patient-Physician Contact Form (Form 1--9) 29(3) Instructions for Using Psychotherapy (Treatment) Follow-up Notes 32(3) Psychotherapy (Treatment) Follow-up Notes (Form 1--10) 35(1) Informed Consent for Treatment With Psychotropic Medications (Form 1--11) 36(2) Medication Log (Form 1--12) 38(1) Clozapine Prescribing and Monitoring Guidelines 39(3) Clozapine Monitoring Form (Form 1--13) 42(3) Rating Scales and Instruments Instructions for Using the 4-Item Positive Symptom Rating Scale (PSRS) and Brief Negative Symptom Assessment (BNSA) 45(7) 4-Item Positive Symptom Rating Scale (PSRS) and Brief Negative Symptom Assessment (BNSA) (Form 1--14) 52(1) Instructions for Using the Brief Bipolar Disorder Symptom Scale (BDSS) 53(7) Brief Bipolar Disorder Symptom Scale (BDSS) (Form 1--15) 60(1) Instructions for Using the Hamilton Rating Scale for Depression (Ham-D) 61(1) Hamilton Rating Scale for Depression (Ham-D) (Form 1--16) 62(3) Instructions for Using the Quick Inventory of Depressive Symptomatology (Self-Report) (QIDS-SR) 65(2) Quick Inventory of Depressive Symptomatology (Self-Report) (QIDS-SR) (Form 1--17) 67(4) Instructions for Using the Mini-Mental State Examination (MMSE) 71(2) Mini-Mental State Examination (MMSE) (Form 1--18) 73(1) Instructions for Using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) 74(1) Yale-Brown Obsessive Compulsive Scale (Y-BOCS) (Form 1--19) 75(1) Instructions for Using the Abnormal Involuntary Movement Scale (AIMS) 76(5) Abnormal Involuntary Movement Scale (AIMS) (Form 1--20) 81(4) Part 2: Information About Psychiatric Illnesses for Patients and Families Information About Alzheimer's Disease for Patients and Families (Form 2--1) 85(4) Information About Anxiety Disorders for Patients and Families (Form 2--2) 89(4) Information About Attention-Deficit/Hyperactivity Disorder for Patients and Families (Form 2--3) 93(4) Information About Bipolar Disorder for Patients and Families (Form 2--4) 97(3) Information About Depressive Disorders for Patients and Families (Form 2--5) 100(5) Information About Obsessive-Compulsive Disorder for Patients and Families (Form 2--6) 105(3) Information About Schizophrenia for Patients and Families (Form 2--7) 108(5) Information About Tardive Dyskinesia for Patients and Families (Form 2--8) 113(4) Part 3: Information About Medications for Patients and Families Antipsychotics Information About Aripiprazole (Abilify) for Patients and Families (Form 3--1) 117(4) Information About Clozapine (Clozaril) for Patient and Families (Form 3--2) 121(4) Information About Olanzapine (Zyprexa) for Patients and Families (Form 3--3) 125(3) Information About Quetiapine (Seroquel) for Patients and Families (Form 3--4) 128(3) Information About Risperidone (Risperdal and Risperdal Consta) for Patients and Families (Form 3--5) 131(3) Information About Ziprasidone (Geodon) for Patients and Families (Form 3--6) 134(3) Information About the First-Generation Antipsychotics for Patients and Families (Form 3--7) 137(5) Information About Haloperidol Decanoate (Haldol Decanoate) and Fluphenazine Decanoate (Prolixin Decanoate) for Patients and Families (Form 3--8) 142(3) Antidepressants Information About Bupropion (Wellbutrin, Wellbutrin SR, Wellbutrin XL) for Patients and Families (Form 3--9) 145(3) Information About Clomipramine (Anafranil) for Patients and Families (Form 3--10) 148(3) Information About Mirtazapine (Remeron) for Patients and Families (Form 3--11) 151(3) Information About Monoamine Oxidase Inhibitors (MAOIs) for Patients and Families (Form 3--12) 154(5) Information About Nefazodone (Serzone) and Trazodone (Desyrel) for Patients and Families (Form 3--13) 159(3) Information About Selective Serotonin Reuptake Inhibitors (SSRIs) for Patients and Families (Form 3--14) 162(4) Information About Tricylic and Tetracyclic Antidepressants (TCAs) for Patients and Families (Form 3--15) 166(4) Information About Venlafaxine (Effexor and Effexor XR) for Patients and Families (Form 3--16) 170(3) Mood Stabilizers Information About Carbamazepine (Tegretol and Tegretol-XR) and Oxcarbazepine (Trileptal) for Patients and Families (Form 3--17) 173(4) Information About Divalproex (Depakote and Depakote ER) and Valproic Acid (Depakene) for Patients and Families (Form 3--18) 177(4) Information About Gabapentin (Neurontin) and Topiramate (Topamax) for Patients and Families (Form 3--19) 181(3) Information About Lamotrigine (Lamictal) for Patients and Families (Form 3--20) 184(3) Information About Lithium for Patients and Families (3--21) 187(4) Antiparkinson Agents Information About Antiparkinson Agents for Patients and Families (Form 3--22) 191(4) Anti-Anxiety / Sedative-Hypnotic Agents Information About Benzodiazepines for Patients and Families (Form 3--23) 195(4) Information About Buspirone (BuSpar) for Patients and Families (Form 3--24) 199(2) Information About Zaleplon (Sonata) and Zolpidem (Ambien) for Patients and Families (Form 3--25) 201(3) Agents for Treatment of ADHD Information About Nonstimulants for the Treatment of Attention-Deficit/Hyperactivity Disorder for Patients and Families (Form 3--26) 204(4) Information About Amphetamines and Methylphenidate for Patients and Families (Form 3--27) 208(5) Cognitive Enhancers Information About Cognitive Enhancers for Patients and Families (Form 3--28) 213(4) References 217(2) Index 219